TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
51 hedge funds and large institutions have $287M invested in Tourmaline Bio in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.17% less ownership
Funds ownership: 7.22% → 7.05% (-0.17%)
37% less capital invested
Capital invested by funds: $457M → $287M (-$170M)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$743K | |
| 2 | +$378K | |
| 3 | +$246K | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$221K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$169K |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$4.17M | |
| 3 | -$621K | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$315K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$224K |